




Searching News Database: AnGes MG
HSMN NewsFeed - 19 Nov 2007
Meyer Pharmaceuticals Acquires NF-kappaB Decoy Technology for Treatment of Inflammatory Disease
Meyer Pharmaceuticals Acquires NF-kappaB Decoy Technology for Treatment of Inflammatory Disease
HSMN NewsFeed - 24 Jan 2007
Vical Highlights Transition to Phase 3 Trial With Allovectin-7(R) for Metastatic Melanoma
Vical Highlights Transition to Phase 3 Trial With Allovectin-7(R) for Metastatic Melanoma
HSMN NewsFeed - 4 Jan 2007
Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Metastatic Melanoma
Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Metastatic Melanoma